NRG Therapeutics
Mathias Frederiksen - Director
Neuroscience
Stevenage, UK
NRG Therapeutics is a neuroscience company advancing a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson’s and ALS/MND